Tradestie Institutional Equity Comparison Engine

AMOD vs SLXN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLXN Overall Edge

SLXN Captures Institutional Edge (2โ€“1 Pillars ยท 2โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Silexion Therapeutics Corp Ordinary Shares (SLXN) driven by superior Growth & Margin, Momentum & Technical while AMOD counters with relative strength in Options & Structure. Fundamentally, AMOD trades at N/M Forward P/E with -127536.2% operating margin (+0.0% YoY revenue) versus SLXN at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, AMOD sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against SLXN sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
AMOD N/M vs SLXN N/M Fwd P/E
Growth & Margin Winner SLXN
Op Margin -127536.2% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner SLXN
1Y -12.9% vs -38.7% ยท 52W Pos 11% vs 31%
Options & Structure Winner AMOD
UNCLASSIFIED (N/A IV) vs BREAKDOWN (N/A IV)
AMOD NASDAQ
Alpha Modus Holdings, Inc. Class A Common Stock
Patent Owners & Lessors
$0.84
-5.14% 1D
Market Cap $51.2M
1M Return -35.01%
1Y Return -12.9%
Forward P/E N/M
Unified AI Score
45.4 / 100 HOLD
Tech 40.0 Fund 59.0 Flow 50.0 Mom 68.9
SLXN NASDAQ
Silexion Therapeutics Corp Ordinary Shares
Biological Products, (No Disgnostic Substances)
$1.76
-11.11% 1D
Market Cap $1.3M
1M Return +1050.33%
1Y Return -38.68%
Forward P/E N/M
Unified AI Score
24.1 / 100 STRONG SELL
Tech 50.0 Fund 32.0 Flow 50.0 Mom 44.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: AMOD -12.9% SLXN -38.68% Spread: +25.78 pp (AMOD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
AMOD TTM Op. Margin: -127536.2% SLXN TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AMOD vs SLXN. Trailing 12-month operating profitability (AMOD -127536.2% vs SLXN 0.0%) and valuation multiples (AMOD N/M vs SLXN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: AMOD (4) vs SLXN (2)
Institutional Metric AMOD SLXN Criterion Row Winner
Market Capitalization Scale $51.2M $1.3M Larger Scale AMOD
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +0.0% Higher Growth Tie
Operating Margin (TTM) Profitability -127536.2% 0.0% Higher Margin SLXN
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 0.0% -897.5% Higher ROE AMOD
52-Week Range Position Momentum 11% ($0โ€“$7) 31% ($0โ€“$5) Stronger Trend SLXN
Beta / 30D Volatility Risk Regime 51.09ฮฒ ยท 120% Vol 28.94ฮฒ ยท 9931% Vol Lower Realized Risk AMOD
Unified Institutional Score Composite Signal 45.4 / 100 (HOLD) 24.1 / 100 (STRONG SELL) Higher Composite AMOD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full AMOD vs SLXN Buy Guide
AMOD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live AMOD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLXN BREAKDOWN
109d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SLXN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither AMOD nor SLXN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.